Responses to Information on Treatments for Depression
1 other identifier
interventional
300
1 country
1
Brief Summary
The purpose of this study is to determine the impact of different messages about depression treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 28, 2020
CompletedFirst Submitted
Initial submission to the registry
November 11, 2020
CompletedFirst Posted
Study publicly available on registry
November 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedSeptember 5, 2021
September 1, 2021
2 months
November 11, 2020
September 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Regressed change from baseline in expectations on the Credibility/Expectancy Questionnaire (CEQ)
The CEQ is a validated, commonly used measure assessing views of the credibility and expectations for benefit from a treatment.
Up to 90 minutes to complete assessment. Assessed immediately pre- and post-intervention (on the same day)
Regressed change from baseline in prognostic pessimism on an adapted version of the Perceptions of Depression Scale (PDS)
Measured using an adapted version of the PDS, a validated scale measuring general prognostic pessimism. Minor changes to wording were made to directly address the three different interventions in the study (CBT, ADM, Combined Treatment).
Up to 90 minutes to complete assessment. Assessed immediately pre- and post-intervention (on the same day)
Secondary Outcomes (5)
Regressed change from baseline in affect on the Positive and Negative Affectivity Scale (PANAS)
Up to 90 minutes to complete assessment. Assessed immediately pre- and post-intervention (on the same day)
Regressed Change from baseline on the Beck Hopelessness Scale (BHS)
Up to 90 minutes to complete assessment. Assessed immediately pre- and post-intervention (on the same day)
Regressed change from baseline in personal and perceived depression stigma on the Depression Stigma Scale (DSS).
Up to 90 minutes to complete assessment. Assessed immediately pre- and post-intervention (on the same day)
Regressed change from baseline in beliefs on the etiology of depression on the Reasons for Depression Questionnaire (RFD).
Up to 90 minutes to complete assessment. Assessed immediately pre- and post-intervention (on the same day)
Willingness to take a next step.
Up to 90 minutes to complete assessment. Assessed at the end of the study questionnaires (same day)
Study Arms (7)
No video
NO INTERVENTIONThis condition involves no video presentation.
CBT without Personalization
EXPERIMENTALVideo provides information about cognitive behavioral therapy.
CBT with Personalization
EXPERIMENTALVideo provides information about cognitive behavioral therapy and describes how treatment can be personalized.
ADM without Personalization
EXPERIMENTALVideo provides information about antidepressant medications.
ADM with Personalization
EXPERIMENTALVideo provides information about antidepressant medications and describes how treatment can be personalized.
Combined Treatment without Personalization
EXPERIMENTALVideo provides information on the combined treatment of cognitive behavioral therapy with antidepressant medications.
Combined Treatment with Personalization
EXPERIMENTALVideo provides information on the combined treatment of cognitive behavioral therapy with antidepressant medications and describes how treatment can be personalized.
Interventions
Intervention involves a video describing CBT without a message about personalization.
Intervention involves a video describing CBT with a message about personalization.
Intervention involves a video describing antidepressant medication without a message about personalization.
Intervention involves a video describing antidepressant medication with a message about personalization.
Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication without a message about personalization.
Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication with a message about personalization.
Eligibility Criteria
You may qualify if:
- PHQ-9 Score indicating a history of elevated depression symptoms
- A high MTurk completion rate
- Must pass all attention checks inserted into the questionnaires
- No history of treatment for depression
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Psychology Building 1835 Neil Avenue
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Strunk, PhD
Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 11, 2020
First Posted
November 20, 2020
Study Start
October 28, 2020
Primary Completion
December 30, 2020
Study Completion
December 30, 2020
Last Updated
September 5, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data available for two years post-publication or at the end of the project if no papers are published.
- Access Criteria
- Will share de-identified data upon reasonable request.
Will share de-identified data upon reasonable request.